Overlooked Roles of DNA Damage and Maternal Age in Generating Human Germline Mutations
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Characterization of Genomic Copy Number Variation in Mus Musculus Associated with the Germline of Inbred and Wild Mouse Populations, Normal Development, and Cancer
Western University Scholarship@Western Electronic Thesis and Dissertation Repository 4-18-2019 2:00 PM Characterization of genomic copy number variation in Mus musculus associated with the germline of inbred and wild mouse populations, normal development, and cancer Maja Milojevic The University of Western Ontario Supervisor Hill, Kathleen A. The University of Western Ontario Graduate Program in Biology A thesis submitted in partial fulfillment of the equirr ements for the degree in Doctor of Philosophy © Maja Milojevic 2019 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Genetics and Genomics Commons Recommended Citation Milojevic, Maja, "Characterization of genomic copy number variation in Mus musculus associated with the germline of inbred and wild mouse populations, normal development, and cancer" (2019). Electronic Thesis and Dissertation Repository. 6146. https://ir.lib.uwo.ca/etd/6146 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. Abstract Mus musculus is a human commensal species and an important model of human development and disease with a need for approaches to determine the contribution of copy number variants (CNVs) to genetic variation in laboratory and wild mice, and arising with normal mouse development and disease. Here, the Mouse Diversity Genotyping array (MDGA)-approach to CNV detection is developed to characterize CNV differences between laboratory and wild mice, between multiple normal tissues of the same mouse, and between primary mammary gland tumours and metastatic lung tissue. -
Review Article PTEN Gene: a Model for Genetic Diseases in Dermatology
The Scientific World Journal Volume 2012, Article ID 252457, 8 pages The cientificWorldJOURNAL doi:10.1100/2012/252457 Review Article PTEN Gene: A Model for Genetic Diseases in Dermatology Corrado Romano1 and Carmelo Schepis2 1 Unit of Pediatrics and Medical Genetics, I.R.C.C.S. Associazione Oasi Maria Santissima, 94018 Troina, Italy 2 Unit of Dermatology, I.R.C.C.S. Associazione Oasi Maria Santissima, 94018 Troina, Italy Correspondence should be addressed to Carmelo Schepis, [email protected] Received 19 October 2011; Accepted 4 January 2012 Academic Editors: G. Vecchio and H. Zitzelsberger Copyright © 2012 C. Romano and C. Schepis. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. PTEN gene is considered one of the most mutated tumor suppressor genes in human cancer, and it’s likely to become the first one in the near future. Since 1997, its involvement in tumor suppression has smoothly increased, up to the current importance. Germline mutations of PTEN cause the PTEN hamartoma tumor syndrome (PHTS), which include the past-called Cowden, Bannayan- Riley-Ruvalcaba, Proteus, Proteus-like, and Lhermitte-Duclos syndromes. Somatic mutations of PTEN have been observed in glioblastoma, prostate cancer, and brest cancer cell lines, quoting only the first tissues where the involvement has been proven. The negative regulation of cell interactions with the extracellular matrix could be the way PTEN phosphatase acts as a tumor suppressor. PTEN gene plays an essential role in human development. A recent model sees PTEN function as a stepwise gradation, which can be impaired not only by heterozygous mutations and homozygous losses, but also by other molecular mechanisms, such as transcriptional regression, epigenetic silencing, regulation by microRNAs, posttranslational modification, and aberrant localization. -
Pedigree-Based and Phylogenetic Methods Support Surprising Patterns of Mutation Rate and Spectrum in the Gray Mouse Lemur
www.nature.com/hdy ARTICLE Pedigree-based and phylogenetic methods support surprising patterns of mutation rate and spectrum in the gray mouse lemur 1,2,8 1,8 1 1,6 1,7 3 C. Ryan Campbell , George P. Tiley , Jelmer W. Poelstra✉ , Kelsie E. Hunnicutt , Peter A. Larsen , Hui-Jie Lee , Jeffrey L. Thorne4, Mario dos Reis 5 and Anne D. Yoder1 © The Author(s), under exclusive licence to The Genetics Society 2021 Mutations are the raw material on which evolution acts, and knowledge of their frequency and genomic distribution is crucial for understanding how evolution operates at both long and short timescales. At present, the rate and spectrum of de novo mutations have been directly characterized in relatively few lineages. Our study provides the first direct mutation-rate estimate for a strepsirrhine (i.e., the lemurs and lorises), which comprises nearly half of the primate clade. Using high-coverage linked-read sequencing for a focal quartet of gray mouse lemurs (Microcebus murinus), we estimated the mutation rate to be among the highest calculated for a mammal at 1.52 × 10–8 (95% credible interval: 1.28 × 10−8–1.78 × 10−8) mutations/site/generation. Further, we found an unexpectedly low count of paternal mutations, and only a modest overrepresentation of mutations at CpG sites. Despite the surprising nature of these results, we found both the rate and spectrum to be robust to the manipulation of a wide range of computational filtering criteria. We also sequenced a technical replicate to estimate a false-negative and false-positive rate for our data and show that any point estimate of a de novo mutation rate should be considered with a large degree of uncertainty. -
10Th Anniversary of the Human Genome Project
Grand Celebration: 10th Anniversary of the Human Genome Project Volume 3 Edited by John Burn, James R. Lupski, Karen E. Nelson and Pabulo H. Rampelotto Printed Edition of the Special Issue Published in Genes www.mdpi.com/journal/genes John Burn, James R. Lupski, Karen E. Nelson and Pabulo H. Rampelotto (Eds.) Grand Celebration: 10th Anniversary of the Human Genome Project Volume 3 This book is a reprint of the special issue that appeared in the online open access journal Genes (ISSN 2073-4425) in 2014 (available at: http://www.mdpi.com/journal/genes/special_issues/Human_Genome). Guest Editors John Burn University of Newcastle UK James R. Lupski Baylor College of Medicine USA Karen E. Nelson J. Craig Venter Institute (JCVI) USA Pabulo H. Rampelotto Federal University of Rio Grande do Sul Brazil Editorial Office Publisher Assistant Editor MDPI AG Shu-Kun Lin Rongrong Leng Klybeckstrasse 64 Basel, Switzerland 1. Edition 2016 MDPI • Basel • Beijing • Wuhan ISBN 978-3-03842-123-8 complete edition (Hbk) ISBN 978-3-03842-169-6 complete edition (PDF) ISBN 978-3-03842-124-5 Volume 1 (Hbk) ISBN 978-3-03842-170-2 Volume 1 (PDF) ISBN 978-3-03842-125-2 Volume 2 (Hbk) ISBN 978-3-03842-171-9 Volume 2 (PDF) ISBN 978-3-03842-126-9 Volume 3 (Hbk) ISBN 978-3-03842-172-6 Volume 3 (PDF) © 2016 by the authors; licensee MDPI, Basel, Switzerland. All articles in this volume are Open Access distributed under the Creative Commons License (CC-BY), which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. -
Postzygotic Mosaicism in Cerebral Cavernous Malformation Matthias Rath ,1,2 Axel Pagenstecher,3 Alexander Hoischen,4 Ute Felbor1,2
Somatic mosaicism J Med Genet: first published as 10.1136/jmedgenet-2019-106182 on 24 August 2019. Downloaded from SHORT REPORT Postzygotic mosaicism in cerebral cavernous malformation Matthias Rath ,1,2 Axel Pagenstecher,3 Alexander Hoischen,4 Ute Felbor1,2 ► Additional material is ABSTRact sporadic CCM cases, variable expressivity based on published online only. To view Background Cerebral cavernous malformations multifocality and incomplete penetrance. please visit the journal online Neither the genetic nor the fundamental bio- (http:// dx. doi. org/ 10. 1136/ (CCMs) can cause severe neurological morbidity but jmedgenet- 2019- 106182). our understanding of the mechanisms that drive logical mechanisms that drive CCM development CCM formation and growth is still incomplete. Recent and disease progression have thus far been fully 1Department of Human experimental data suggest that dysfunctional CCM3- clarified. Decades ago, Rudolf Happle anticipated Genetics, University Medicine deficient endothelial cell clones form cavernous lesions in that mutational events - genetic or epigenetic - could Greifswald, Greifswald, Germany conjunction with normal endothelial cells. generate new aberrant cell clones that - in case of a 2Interfaculty Institute of Objective In this study, we addressed the question lethal mutation - would survive only in close prox- Genetics and Functional whether endothelial cell mosaicism can be found in human imity to normal cells, thereby creating characteristic Genomics, University of cavernous tissue of CCM1 germline -
Overlooked Roles of DNA Damage and Maternal Age in Generating Human Germline Mutations
Overlooked roles of DNA damage and maternal age in generating human germline mutations Ziyue Gaoa,b,1, Priya Moorjanic,d, Thomas A. Sasanie, Brent S. Pedersene, Aaron R. Quinlane,f, Lynn B. Jordee, Guy Amsterg,2, and Molly Przeworskig,h,1,2 aHoward Hughes Medical Institute, Stanford University, Stanford, CA 94305; bDepartment of Genetics, Stanford University, Stanford, CA 94305; cDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720; dCenter for Computational Biology, University of California, Berkeley, CA 94720; eDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112; fDepartment of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, UT 84108; gDepartment of Biological Sciences, Columbia University, New York, NY 10027; and hDepartment of Systems Biology, Columbia University, New York, NY 10027 Edited by James A. Birchler, University of Missouri, Columbia, MO, and approved April 2, 2019 (received for review January 23, 2019) The textbook view that most germline mutations in mammals Insight into the genesis of germline mutations can also be arise from replication errors is indirectly supported by the fact that gained by contrasting male and female mutation patterns, which there are both more mutations and more cell divisions in the male reflect distinct developmental trajectories and epigenetic dy- than in the female germline. When analyzing large de novo namics. In mammals, fathers contribute more de novo mutations mutation datasets in humans, -
Similarities and Differences in Patterns of Germline Mutation Between Mice and Humans
ARTICLE https://doi.org/10.1038/s41467-019-12023-w OPEN Similarities and differences in patterns of germline mutation between mice and humans Sarah J. Lindsay 1, Raheleh Rahbari 1, Joanna Kaplanis1, Thomas Keane 1 & Matthew E. Hurles1 Whole genome sequencing (WGS) studies have estimated the human germline mutation rate per basepair per generation (~1.2 × 10−8) to be higher than in mice (3.5–5.4 × 10−9). In humans, most germline mutations are paternal in origin and numbers of mutations per 1234567890():,; offspring increase with paternal and maternal age. Here we estimate germline mutation rates and spectra in six multi-sibling mouse pedigrees and compare to three multi-sibling human pedigrees. In both species we observe a paternal mutation bias, a parental age effect, and a highly mutagenic first cell division contributing to the embryo. We also observe differences between species in mutation spectra, in mutation rates per cell division, and in the parental bias of mutations in early embryogenesis. These differences between species likely result from both species-specific differences in cellular genealogies of the germline, as well as biological differences within the same stage of embryogenesis or gametogenesis. 1 Wellcome Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. Correspondence and requests for materials should be addressed to M.E.H. (email: [email protected]) NATURE COMMUNICATIONS | (2019) 10:4053 | https://doi.org/10.1038/s41467-019-12023-w | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12023-w ost germline single-nucleotide mutations in humans (2.7:1 and 3.9:1, respectively1,3–5), given the fivefold difference in (75–80%) are paternal in origin, and increasing paternal the ratios of genome replications in the paternal and maternal M 6 age is the major factor determining variation in num- germlines between mice (2.5:1) and humans (13:1) . -
Common Postzygotic Mutational Signature in Multiple Healthy Adult Tissues Related To
bioRxiv preprint doi: https://doi.org/10.1101/2020.02.17.952473; this version posted March 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Common postzygotic mutational signature in multiple healthy adult tissues related to 2 embryonic hypoxia 3 Yaqiang Hong1,3,14, Dake Zhang1,2,14, Xiangtian Zhou4,5,14, Aili Chen1,14, Amir Abliz6,14, Jian Bai1, Liang 4 Wang7,8, Qingtao Hu1, Kenan Gong1, Xiaonan Guan1,13, Mengfei Liu6, Xinchang Zheng1,13, Shujuan Lai1, 5 Hongzhu Qu9, Fuxin Zhao4,5, Shuang Hao1, Zhen Wu7,8, Hong Cai6, Shaoyan Hu10, Yue Ma11, Junting 6 Zhang7,8, Yang Ke6, Qianfei Wang1, Wei Chen1,2, *, Changqing Zeng1,12, 13,* 7 1 Key Laboratory of Genomic and Precision Medicine of Chinese Academy of Sciences, Beijing Institute of 8 Genomics, Beijing, China 9 2 Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical 10 Engineering, Beihang University, Beijing, China 11 3 Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China 12 4 School of Optometry and Ophthalmology and Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 13 China 14 5 State Key Laboratory Cultivation Base and Key Laboratory of Vision Science, Ministry of Health P. R. China 15 and Zhejiang Provincial Key Laboratory of Ophthalmology and Optometry, Wenzhou, Zhejiang, China -
Early Somatic Mosaicism Is a Rare Cause of Long-QT Syndrome
Early somatic mosaicism is a rare cause of long-QT syndrome James Rush Priesta,b,c, Charles Gawadb,d,1, Kristopher M. Kahlige, Joseph K. Yuf,g, Thomas O’Haraf, Patrick M. Boylef,g, Sridharan Rajamanie,2, Michael J. Clarkh, Sarah T. K. Garciah,3, Scott Ceresnaka,b,c, Jason Harrish, Sean Boyleh, Frederick E. Deweya,i,4, Lindsey Malloy-Waltona,b,c,5, Kyla Dunna,j, Megan Grovea,i, Marco V. Pereza,i, Norma F. Neffk, Richard Chenh, Katsuhide Maedaa,l, Anne Dubina,b,c, Luiz Belardinellie, John Westh, Christian Antolikm, Daniela Macayam, Thomas Quertermousa,i, Natalia A. Trayanovaf,g, Stephen R. Quakek,n,o,6, and Euan A. Ashleya,b,i,6 aStanford Center for Inherited Cardiovascular Disease, Stanford University School of Medicine, Stanford, CA 94305; bChild Health Research Institute, Stanford University School of Medicine, Stanford, CA 94305; cDivision of Pediatric Cardiology, Stanford University School of Medicine, Stanford, CA 94305; dDivision of Pediatric Hematology-Oncology, Stanford University School of Medicine, Stanford, CA 94305; eDepartment of Biology, Cardiovascular Therapeutic Area, Gilead Sciences, Fremont, CA 94555; fDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218; gInstitute for Computational Medicine, Johns Hopkins University, Baltimore, MD 21218; hPersonalis, Inc., Menlo Park, CA 94025; iDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305; jLucile Packard Children’s Hospital Heart Center, Palo Alto, CA 94304; kDepartment of Bioengineering, Stanford University School of Medicine, Stanford, CA 94305; lDivision of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA 94305; mCardiogenetic Testing Services, GeneDx, Gaithersburg, MD 20877; nDepartment of Applied Physics, Stanford University, Stanford, CA 94305; and oHoward Hughes Medical Research Institute, Stanford University School of Medicine, Stanford, CA 94305 Contributed by Stephen R. -
Interpreting the Dependence of Mutation Rates on Age and Time
Interpreting the dependence of mutation rates on age and time Ziyue Gao1,+,*, Minyoung J. Wyman2, Guy Sella2 and Molly Przeworski2,3,+ 1 Committee on Genetics, Genomics and Systems Biology, University of Chicago 2 Dept. of Biological Sciences, Columbia University 3 Dept. of Systems Biology, Columbia University + To whom correspondence should be addressed: [email protected] or [email protected] * Current address: 606D Fairchild Center, M.C. 2424, New York, NY 10027 Abstract Mutations can arise from the chance misincorporation of nucleotides during DNA replication or from DNA lesions that are not repaired correctly. We introduce a model that relates the source of mutations to their accumulation with cell divisions, providing a framework for understanding how mutation rates depend on sex, age and absolute time. We show that the accrual of mutations should track cell divisions not only when mutations are replicative in origin but also when they are non-replicative and repaired efficiently. One implication is that the higher incidence of cancer in rapidly renewing tissues, an observation ascribed to replication errors, could instead reflect exogenous or endogenous mutagens. We further find that only mutations that arise from inefficiently repaired lesions will accrue according to absolute time; thus, in the absence of selection on mutation rates, the phylogenetic “molecular clock” should not be expected to run steadily across species. 1 Introduction Because mutations are the ultimate source of all genetic variation, deleterious and advantageous, mutagenesis has been of central interest even before the discovery of DNA as the genetic material (e.g., Muller, 1927) and developing a model of mutations along the genome is a major focus of current disease mapping studies (Lawrence et al., 2013, Samocha et al., 2014). -
Mosaicism of Activating FGFR3 Mutations in Human Skin Causes Epidermal Nevi
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi Christian Hafner, … , Ellen C. Zwarthoff, Arndt Hartmann J Clin Invest. 2006;116(8):2201-2207. https://doi.org/10.1172/JCI28163. Research Article Dermatology Epidermal nevi are common congenital skin lesions with an incidence of 1 in 1,000 people; however, their genetic basis remains elusive. Germline mutations of the FGF receptor 3 (FGFR3) cause autosomal dominant skeletal disorders such as achondroplasia and thanatophoric dysplasia, which can be associated with acanthosis nigricans of the skin. Acanthosis nigricans and common epidermal nevi of the nonorganoid, nonepidermolytic type share some clinical and histological features. We used a SNaPshot multiplex assay to screen 39 epidermal nevi of this type of 33 patients for 11 activating FGFR3 point mutations. In addition, exon 19 of FGFR3 was directly sequenced. We identified activating FGFR3 mutations, almost exclusively at codon 248 (R248C), in 11 of 33 (33%) patients with nonorganoid, nonepidermolytic epidermal nevi. In 4 of these cases, samples from adjacent histologically normal skin could be analyzed, and FGFR3 mutations were found to be absent. Our results suggest that a large proportion of epidermal nevi are caused by a mosaicism of activating FGFR3 mutations in the human epidermis, secondary to a postzygotic mutation in early embryonic development. The R248C mutation appears to be a hot spot for FGFR3 mutations in epidermal nevi. Find the latest version: https://jci.me/28163/pdf Research article Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi Christian Hafner,1 Johanna M.M. van Oers,2 Thomas Vogt,1 Michael Landthaler,1 Robert Stoehr,3 Hagen Blaszyk,4 Ferdinand Hofstaedter,5 Ellen C. -
Non-Autonomous Effects of CCM Genes Loss
Finetti et al. Vessel Plus 2021;5:29 Vessel Plus DOI: 10.20517/2574-1209.2021.49 Minireview Open Access Non-autonomous effects of CCM genes loss Federica Finetti, Lorenza Trabalzini Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 253100, Siena, Italy. Correspondence to: Prof. Lorenza Trabalzini, Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 253100, Siena, Italy. E-mail: [email protected] How to cite this article: Finetti F, Trabalzini L. Non-autonomous effects of CCM genes loss. Vessel Plus 2021;5:29. https://dx.doi.org/10.20517/2574-1209.2021.49 Received: 26 Mar 2021 First Decision: 15 Apr 2021 Revised: 23 Apr 2021 Accepted: 18 May 2021 Published: 11 Jun 2021 Academic Editor: Jun Zhang Copy Editor: Yue-Yue Zhang Production Editor: Yue-Yue Zhang Abstract Cerebral cavernous malformation (CCM) is a rare disease of proven genetic origin characterized by vascular lesions affecting capillaries and small vessels of the central nervous system. CCM lesions occur in a range of different phenotypes, including wide differences in lesion number, size, and susceptibility to intracerebral hemorrhage. CCM lesion genesis requires loss of function of any of three genes, namely KRIT1 (CCM1), MGC4607 (CCM2), and PDCD10 (CCM3). These genes exert pleiotropic effects regulating multiple mechanisms involved in angiogenesis, cellular response, cell-cell and cell-matrix adhesion, cytoskeleton dynamics, and oxidative damage protection. Familial CCM is an autosomal-dominantly inherited disease in which the loss of any of the three CCM genes follows a two-hit mechanism. The heterozygous loss-of-function germline variants in one of the involved genes seems to be associated with a second postzygotic mutation, according to Knudson’s two-hit model of tumor suppressor genes.